Also, compared with the DSS group, PS pretreatment not only resulted in lower colonic IBD-associated myeloperoxidase (MPO) activity [1] but also in less splenomegaly (indication of inflammation severity) (Figure 4g,h). Here, MPO is linked to inflammatory bowel disease.